Lilian Stern has been a senior investor relations counselor in the biotechnology industry for over 15 years, representing more than 200 companies ranging from start-ups to large-cap public companies, in a broad range of development stages and therapeutic areas. As Principal of Stern IR, she works closely with client teams, providing skilled and knowledgeable IR counsel. Prior to founding Stern IR, Lilian established and ran the investor relations group at Burns McClellan for six years and worked as a biotechnology sell-side analyst at Donaldson, Lufkin & Jenrette/Credit Suisse First Boston. She holds an A.B. with distinction from Cornell University and a J.D. with honors from Harvard Law School.